CanniMed Therapeutics Inc. Announces 2017 Third Quarter Results Release Date
September 05 2017 - 7:00AM
Business Wire
CanniMed Therapeutics Inc. (TSX:CMED) (“CanniMed” or
the “Company”) announces that it plans to release its financial
results for the three and nine months ended July 31, 2017 before
markets open on Monday September 11, 2017.
About CanniMed Therapeutics Inc.
CanniMed is a Canadian-based, international plant
biopharmaceutical company and a leader in the Canadian medical
cannabis industry, with 15 years of pharmaceutical cannabis
cultivation experience, state-of-the-art, GMP-compliant production
process and world class research and development platforms with a
wide range of pharmaceutical-grade cannabis products. In addition,
the Company has an active plant biotechnology research and product
development program focused on the production of plant-based
materials for pharmaceutical, agricultural and environmental
applications.
The Company, through its subsidiaries, was the first producer to
be licensed under the Marihuana for Medical Purposes Regulations,
the predecessor to the current Access to Cannabis for Medical
Purposes Regulations. It was the sole supplier to Health Canada
under the former medical marijuana system for 13 years, and has
been producing safe and consistent medical marijuana for thousands
of Canadian patients, with no incident of product diversion or
recalls.
For more information, please visit our websites: www.cannimed.ca
(patients) and www.cannimedtherapeutics.com (investors).
Notice Regarding Forward Looking Statements
This news release contains forward-looking statements within the
meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements
regarding future estimates, plans, programs, forecasts,
projections, objectives, assumptions, expectations or beliefs of
future performance, are “forward-looking statements”.
Forward-looking statements can be identified by the use of words
such as “plans”, “expects” or “does not expect”, “is expected”,
“estimates”, “intends”, “anticipates” or “does not anticipate”, or
“believes”, or variations of such words and phrases or state that
certain actions, events or results “may”, “could”, “would”, “might”
or “will” be taken, occur or be achieved.
Forward-looking statements are based on assumptions and involve
known and unknown risks, uncertainties and other factors which may
cause the actual results, performance or achievements of CanniMed
Therapeutics Inc. to be materially different from any future
results, performance or achievements expressed or implied by the
forward-looking statements, including the risks described in
CanniMed Therapeutics Inc.’s documents filed with applicable
Canadian securities regulatory authorities which may be viewed at
www.sedar.com . The forward-looking statements included in this
news release are made as of the date of this news release. CanniMed
Therapeutics Inc. does not undertake to publicly update such
forward-looking statements to reflect new information, subsequent
events or otherwise, unless required by applicable securities
legislation.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170905005352/en/
For more information or to schedule an interview, please
contact:CanniMed Therapeutics Inc.Dara Willis,
416-836-9272media@cannimed.com